Interstitial Lung Abnormality, Interstitial Lung Disease, and Lung Cancer
Hiroto Hatabu, MD, PhD, FACR+more
As a practicing chest radiologist in Boston, one of this article’s authors (Dr. Hatabu) encounters several patients with drug-related pneumonitis (DRP) daily when on clinical duty. Sometimes DRP coexists with […] Read more
Alexander Drilon, MD
Alexander Drilon, MD, is now Memorial Sloan Kettering Cancer Center’s Chief of the Early Drug Development (EDD) Service in the Division of Solid Tumor Oncology of the Department of Medicine. […] Read more
Pembrolizumab Is Active in Lung Cancer Brain Metastases
Sarah B. Goldberg, MDIn Reference To: Goldberg SB, Schalper KA, Gettinger SN, et al. Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, […] Read more
The Role of Nurse Navigators in Lung Cancer: Advocates, Sounding Boards, and Care Coordinators for Patients
Megan Roy, BSN, RN, OCNMy primary goal as a nurse navigator is to provide patient-centered care while facilitating timely access to the right providers. Nurse navigators have the clinical expertise to individualize both their […] Read more
Using Tumor Radiomic Features To Predict NSCLC Chemotherapy Response
Michelle Hershman, MD+more
IN REFERENCE TO: Khorrami M, Jain P, Bera K, et al. Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features. Lung Cancer. 2019;135:1-9. Read more
In Memorium: Tobacco-Control Innovator, Former President of Uruguay, Dr. Tabaré Vázquez Dies from Lung Cancer at 80
Former President of Uruguay and oncologist, Dr. Tabaré Vázquez, died at age 80 from lung cancer on December 6, 2020. He became the first Socialist leader of Uruguay during his […] Read more
Growing Importance and Changing Dynamics: Social Media’s Ever-Changing Role in Thoracic Oncology
H. Jack West, MDAlthough some resist its gravitational pull, social media and especially Twitter are becoming an increasingly valuable tool in academic and community-based cancer care, with thoracic oncology helping set the pace […] Read more
Speaking as a medical oncologist who cares for patients with lung cancer, the present is filled with much hope. There has been a profusion of studies that report increasingly improved […] Read more
A Lack of Standardization in Toxicity Reporting Leaves the Field Open to Misinformation
Emily A. Simons, MD, MPH+more
With many new lung cancer treatments approved through accelerated tracks based on early-phase (I/II) trial data, we have become increasingly aware of the lack of standards for disclosing toxicities when […] Read more
High Risk of Thromboembolic Events in Patients With NSCLC With ALK/ROS1 Fusions
Chuchu Shao, MD+more
The relationship between cancer and thromboembolic events as been widely studied since 1895. As we know, venous thromboembolism (VTE) is a well-recognized complication of malignancy, including pulmonary embolism (PE), deep-vein […] Read more